Massachusetts Surveillance of Opioid-involved Morbidity and - - PowerPoint PPT Presentation

massachusetts surveillance
SMART_READER_LITE
LIVE PREVIEW

Massachusetts Surveillance of Opioid-involved Morbidity and - - PowerPoint PPT Presentation

Massachusetts Surveillance of Opioid-involved Morbidity and Mortality Northeast Epidemiology Conference Northampton, MA October 20, 2017 Stefanie Albert, MPH Anna Agan, MPH Office of Integrated Surveillance and Informatics Services Office


slide-1
SLIDE 1

Massachusetts Surveillance

  • f Opioid-involved

Morbidity and Mortality

Northeast Epidemiology Conference Northampton, MA October 20, 2017 Anna Agan, MPH Office of Statistics and Evaluation Bureau of Community Health and Prevention Massachusetts Department of Public Health Stefanie Albert, MPH Office of Integrated Surveillance and Informatics Services Bureau of Infectious Disease and Laboratory Sciences Massachusetts Department of Public Health

slide-2
SLIDE 2

Drug Deaths: A National Epidemic

2

Source: The New York Times, 6/5/2017

slide-3
SLIDE 3

Impact on Massachusetts

3

Source: MDPH Data Brief, August 2017

slide-4
SLIDE 4

Impact on Massachusetts

4

Source: MA Chapter 55 Overdose Report, August 2017

slide-5
SLIDE 5

Enhanced State Opioid Overdose Surveillance (ESOOS) Grant

5

Increase the timeliness of reporting non- fatal and fatal opioid overdoses and associated risk factors Disseminate surveillance findings to key stakeholders Share data with the CDC to support improved multi-state surveillance of and response to opioid-involved overdoses

GOALS

slide-6
SLIDE 6

6

ESOOS: Data Sources

Massachusetts Ambulance Trip Record Information System (MATRIS) ESSENCE – Emergency Department Syndromic Surveillance (SyS ED) State Unintentional Drug Overdose Reporting System (SUDORS)

slide-7
SLIDE 7

All 3 data sources: Date/time, location, demographics

MATRIS

  • Ambulance services

across all of the Commonwealth are reporting

  • Opioid definition has

several priority levels

  • Available data includes

patient demographics, clinical information, incident details such as narrative, location, date/time, disposition

  • Limitations: timeliness
  • f data submission
  • 63 facilities, ~85% of all

MA ED visits

  • Available data includes

free-text and coded data

  • n patient demographics

and clinical information, encounter details such as patient stated chief complaint, disposition

  • Limitations: geographic

capture, variations in text and coded data

ESSENCE SUDORS

  • Combines information

from the death certificate, medical examiner records, law enforcement reports, past medical history, and toxicology reports for all deaths in Massachusetts

  • Has capability be

modified to address emerging issues

  • Limitations: only six

months of complete data

ESOOS: Data Sources

7

slide-8
SLIDE 8

ESOOS: SUDORS

8

Demographics

  • Age
  • Sex
  • Race/ethnicity
  • City and country of

residence

  • Marital status
  • Education level
  • Usual occupation

Injury and Death

  • Date
  • Location
  • Detailed toxicology
  • Scene evidence
  • Date/time last

known alive

  • Bystanders present
  • Naloxone

administration Circumstances

  • Mental health and

substance abuse history

  • Current/ever

treated for substance abuse

  • Recent release

from an institution

  • Pain treatment

history

slide-9
SLIDE 9

ESOOS: SUDORS

9

Source: MA SUDORS, September 2017 (Preliminary Data)

13% 13% 74%

slide-10
SLIDE 10

ESOOS: Non-Fatal and Fatal Opioid Overdoses in Massachusetts, 2016

10

Source: ESSENCE and MATRIS, July 2017 MDPH Data Brief, August 2017 (Preliminary Data)

2,107 Deaths*

10,875 SyS ED visits 20,987 EMS incidents

*Confirmed and estimated deaths

slide-11
SLIDE 11

11

ESOOS: Non-Fatal and Fatal Opioid Overdoses in Massachusetts, 2016

Source: ESSENCE and MATRIS, July 2017 (Preliminary Data)

slide-12
SLIDE 12

ESOOS: Non-Fatal and Fatal Opioid Overdoses in Massachusetts, 2016

12

Source: ESSENCE and MATRIS, July 2017; MDPH Data Brief, August 2017 (Preliminary Data)

slide-13
SLIDE 13

ESOOS: Non-Fatal and Fatal Opioid Overdoses in Massachusetts, 2016

13

Source: ESSENCE and MATRIS, July 2017; MDPH Data Brief, August 2017 (Preliminary Data)

slide-14
SLIDE 14

Acknowledgements and Contact Information

  • This presentation was a collaborative effort between the Massachusetts

Injury Surveillance Program and Syndromic Surveillance team

  • With special thanks to Dana Bernson, Mark Bova, Kate Chamberlin, Rosa

Ergas, Ridgely Ficks, Cassidy Heverling, Lauren Larochelle, and Jeffrey Yu

  • Funded by the Centers for Disease Control and Prevention (CDC)

Contact information

Anna Agan, MPH anna.agan@state.ma.us Stefanie Albert, MPH stefanie.albert@state.ma.us Massachusetts Syndromic Surveillance syndromic-surveillance@state.ma.us

14